Fujimoto A, Ichinose Y, Matsuura K, Mikami E, et al. Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan. BMC Cancer 2026 Jul 13. doi: 10.1186/s12885-026-16548.
PMID: 42437898